General Information of Drug (ID: DMQYK7Y)

Drug Name
Anti-CD19 "armored" CAR-Tcell therapy
Indication
Disease Entry ICD 11 Status REF
Chronic lymphocytic leukaemia 2A82.0 Phase 1 [1]
Cross-matching ID
TTD ID
D0NW8L

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)